News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Norwegian Parent Vaccine Never Released In Norway

Norwegian "Parent Vaccine" Never Released In Norway

By Jon Eisen

(In an exclusive to, Jonathan Eisen reveals that the now-famous "Norwegian parent vaccine" from which the New Zealand meningococcal vaccine was "derived" and which has been used to justify claims of "safety" and "efficacy"... was not even released in Norway, after scientists rejected it on the ground that it was only marginally effective, and that the meningitis epidemic in Norway had tapered off without the vaccine.

NZ Ministry of Health Book Admits ("Immunisation Handbook 2002")

There are now some very serious questions being asked by scientists, doctors and medical researchers about both the safety as well as the efficacy of the MeNZB vaccine, especially now that Chiron, the manufacturer of the vaccine is in the news in the UK and USA for the contamination of its latest flu vaccine.

It appears as though there is a huge problem with the case that the NZ Ministry of Health has made to the NZ public.

One of the key points is that the Norwegian "parent" vaccine on whose "success" the MoH has based much of its sell to the NZ public, was never generally released in Norway. However, the Ministry actually cites this fact in its "Immunisation Handbook 2002", though public announcements in the run up to the vaccine "roll out" have never cited this fact.

After very extensive trials on about 180,000 children and teens, the Norwegian authorities concluded that it simply was not sufficently effective to merit general release. Moreover, the Norwegian meningococcal epidemic was well on the wane anyhow without any vaccine (see below for details).

Something similar has happened in New Zealand, where both deaths and notifications from meningococcal disease have reduced by 75% and 50% respectfully, in the last three years (with no vaccine).

A summary of the main points about the vaccine:

•Does the vaccine actually work as advertised?

While there may be some benefits from the vaccine, it’s difficult to know for sure. The manufacturer’s own data sheet says that “no prospective efficacy trials have been performed with MeNZB”. The Ministry of Health says that the vaccination programme is proceeding …“without efficacy data.”

In other words, there is no proof that the vaccine will in fact prevent meningoccocal disease.

•Is the MeNZB vaccine safe?

This is also difficult to establish. There are many risks that may be as yet unknown. The MeNZB is a new vaccine with a very limited trial period and limited trial numbers of individuals who participated (about 1600). Moreover, these people were followed up for only “up to seven days” to monitor “adverse events”. However, some of the more serious “adverse events” that may happen with vaccines may not show up for many years. Some vaccines that are still being promoted as “safe and effective” are now believed by many researchers to cause some kinds of cancer, insulin dependent diabetes and autism. .

• Adverse reactions/effectiveness

Most vaccines have some adverse reactions, which can range in severity from trivial to life-threatening.The adverse reactions reported to date following the MeNZB vaccine are relatively minor such as soreness at the injection site, low grade fever and mood changes. However, with every vaccine there is the potential for serious long term side effects. The Norwegian meningococcal B vaccine, on which the NZ vaccine is based, caused a number of serious side effects, including allergic shock, blood in the urine as well as some long term health problems such as Guillain-Barre Syndrome (a neurological disorder that can include paralysis) and ME (Chronic Fatigue syndrome). While it is not yet known whether the MeNZB vaccine could cause these conditions, the fact that they have been associated with a very similar vaccine is cause for concern. Many of these problems will only become apparent after long-term follow up of vaccine recipients.

• Professor Dianna Lennon of Auckland University, principal researcher on the vaccine, has revealed that it is not even known whether the increase in antibodies occuring in people who have been inoculated (about 25% have no antibody response), is sufficient to provide protection against the disease. (Moreover, it is not yet known how long the elevated levels of antibodies will last.)

• The full extent of the safety and effectiveness of MeNZB will only be known after the vaccination campaign is finished if the data gathered is released by the MoH.

In the meantime, the NZ vaccination programme must be considered “experimental.”

• The Norwegian “Parent Vaccine”

The MoH has tried to allay concerns over the MeNZB vaccine by referring to the extensive trials conducted in Norway on the Norwegian “parent vaccine” (similar to the MeNZB), which was tested on 180,000 adolescents.

However, what the MoH seldom tells the public is that outside of the trials, the Norwegian vaccine was never even used, after researchers concluded that it wasn't effective enough to justify a national campaign. According to The Lancet “the calculated rate of protection (57.2%)” was not high enough to justify a full-scale programme. According to the NZ MoH Immunisation Handbook(2002) the epidemic was naturally declining in Norway anyhow, without a full scale vaccination campaign. Furthermore, the Norwegian tests never involved participants younger than 14, while the MoH is hoping to vaccinate all young New Zealanders from 20 years down to 6 month old babies!

Does Meningococcal B ‘cause’ the disease?

• The Ministry of Health acknowledges the meningococcal bacterium lives harmlessly in the throats and nasal passages of up to 45% of all New Zealanders. Since it is not contagious, why do some people fall ill to the “disease” while the vast majority do not?

A depleted and overtaxed immune system is the most likely answer. Indeed, in 2000, Minister of Health Annette King, said that this disease was a “disease of poverty”. In NZ as elsewhere people living in poverty often have poor nutrition. Specifically, deficiencies in vitamin C and iron have been found to increase the risk of children developing meningococcal disease. Regardless of family income, some children and teenagers may also have exposure to excessive amounts of sugar, food additives and other toxins (such as cigarette smoke), which may also deplete the immune system.

• Is there really an “epidemic” of the disease in New Zealand?

It all depends on what you mean by the term “epidemic”. In the last 10 years 70,000 people have died from cancer. 60,000 have died from heart disease and 15,000 people have died from “preventable medical injury”. In that time 150 people have died from meningococcal B disease.

In any event, the number of deaths has decreased in the last three years by 75% and the number of cases has declined by 50%. This is prior to the introduction of the vaccine. The reasons for this decline have not been explained by the MoH.

• More facts about the MeNZB vaccine

• SECRET INGREDIENTS: Many of the ingredients in the vaccine are considered to be “proprietary”. In other words, neither the Ministry of Health nor the manufacturer will disclose everything that’s in the vaccine. Medsafe, the Ministry of Health agency which licenses pharmaceutical medicines and vaccines, has refused to state what medium was used to culture the bacteria used in the MeNZB vaccine, what agents were used to deactivate the bacteria, and what agents were used to purify the vaccine.

• The MoH admits that the vaccine contains aluminium hydroxide, a proven neurotoxin (nerve poison), and that there is no safety data on its use with other vaccines.

The obvious question then becomes, "Can you give an “informed consent” to a vaccine without knowing what’s in it?"

The MoH has likewise refused to give information about the selection process for participants in the vaccine trial, or whether (or why) any withdrew from the vaccine trial and if they did withdraw, whether they have been followed up. (Many trials can be and have been manipulated by the participant selection process and by removing mention of those who withdraw.)

•Don’t scientists believe that vaccines are good?

Science and medicine are by no means unanimous about vaccines. In fact, there is a long-running controversy about both the safety as well as the effectiveness of many vaccines. Many doctors and scientists think that vaccines are generally safe and effective. However, many other doctors and scientists disagree. The safety and effectiveness of the NZ Meningococcal B vaccine are also now a matter of contention among doctors and health professionals.

• For more information about meningococcal disease, the MeNZB and other vaccines:

Immunisation Awareness Society: Red Flags Weekly: ALSO:

There is a Public Meeting on the vaccine to be held on October 28 at 7pm (Trades Union Hall, Great North Rd, Ak)

P.S. For additional coverage of this issue, please look out for the new issue of HEALTHY OPTIONS magazine at the end of October for a brilliant expose of the whole affair by Ron Law, former expert consultant to the Ministry of Health. In addition, the current issue of INVESTIGATE magazine has an excellent piece called "Poisoned Apple" by Barbara Sumner-Burstyn on the coverup of the failure of the MeNZB vaccine. In addition there is a piece by me on what the vaccine "package insert" actually says about how poorly this vaccine was trialled.

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Joel Coen's Monochromatic Macbeth

The Bard of Avon may well be smirking up the sleeves of his lace doublet at the irony of Will Smith's Oscar debacle, but now that the initial furore has dissipated, it's worth revisiting the movie for which Denzel Washington was also nominated. More>>

Howard Davis: Kenneth Branagh’s Black & White Belfast

Branagh has assembled a wonderful cast, including Ciarán Hinds, a gently formidable actor who well deserves his Oscar nomination, and Judi Dench, who steals every scene she’s in. More>>

Howard Davis: Dennis Villeneuve’s Dune - A Brief History

So many elements of Herbert’s novel have since become tropes of popular SciFi that Villeneuve’s film sometimes seems deceptively derivative. What makes all this nonsense essential viewing is his astonishing visual sensibility. More>>

Howard Davis: Jill Trevelyan's Rita Angus

Although Angus has become one of Aotearoa’s best-loved painters, the story of her life remained little known and poorly understood before Jill Trevelyan's acclaimed and revelatory biography, which has been republished by Te Papa press. More>>



  • Wellington
  • Christchurch
  • Auckland